58 results
DEFA14A
TSHA
Taysha Gene Therapies Inc
18 Apr 24
Additional proxy soliciting materials
4:21pm
Additional Materials
Soliciting Material under §240.14a-12
Taysha Gene Therapies, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
You invested in TAYSHA
D
11uqpcsojibg3gm2k
25 Aug 23
$150.00 mm in equity / options, sold $149.95 mm, 42 investors
4:29pm
8-K
EX-10.1
qbd3 zca6t4
14 Aug 23
Entry into a Material Definitive Agreement
7:29am
DEFA14A
aee y1bm1p
8 May 23
Additional proxy soliciting materials
4:04pm
PRE 14A
x77nazf3s6bmhvwz4i
27 Apr 23
Preliminary proxy
4:03pm
D
1ke5v0a54 u6lkyhyyw
7 Nov 22
$30.00 mm in equity, sold $30.00 mm, 1 investor
8:45am
8-K/A
EX-10.2
6gfuvu 6xzv708n6
31 Oct 22
Entry into a Material Definitive Agreement
8:45am
8-K/A
EX-10.1
bhg0 7pyzrxrqrw
31 Oct 22
Entry into a Material Definitive Agreement
8:45am
8-K
EX-1.1
98edlsx0
27 Oct 22
Taysha Announces Pricing of Public Offering of Common Stock
5:18pm